23%

CA Patient Healthcare Research

Questions marked with a * are required
LDA Research is an international qualitative market research provider specialising in the pharmaceutical and medical device sector.

For this study, we are looking for adults living in Canada who have been diagnosed with IgA Nephropathy (IgAN), Multiple Sclerosis (MS), Hypercholesterolaemia or Lupus Nephritis to take part in a research interview exploring their experiences of living with their condition, managing their treatment and accessing patient support services.

The research will involve a 60-minute online interview, and participants who successfully complete the interview will receive CAD$150 as a thank you for their time.

Please complete the brief questions below to determine your eligibility. If you qualify for the research, a member of our team will be in touch to discuss the next steps.

Please note that if you meet the eligibility criteria for this study, you will be asked to provide documentation confirming your diagnosis before your participation can be confirmed. This could include a letter from your healthcare professional or relevant medical documentation showing your diagnosis.

Any documentation provided will be treated confidentially and handled securely in accordance with applicable data protection requirements.

We are committed to protecting the personal data of any respondent that participates in the course of our research and as such we seek consent on a regular basis to both maintain and process your personal data.

We will always ask for your consent before collecting any personal data, and it is within your rights to withdraw this consent at any point.

By answering the following screening questions, you will provide minimal data pertinent to the study, which will be processed in line with GDPR legislation. Are you happy to continue?
LDA Research is an international qualitative market research provider specialising in the pharmaceutical and medical device sector.For this study, we are looking for adults living in Canada who have been diagnosed with IgA Nephropathy (IgAN), Multiple Sclerosis (MS), Hypercholesterolaemia or Lupus Nephritis to take part in a research interview exploring their experiences of living with their condition, managing their treatment and accessing patient support services.The research will involve a 60-minute online interview, and participants who successfully complete the interview will receive CAD$150 as a thank you for their time.Please complete the brief questions below to determine your eligibility. If you qualify for the research, a member of our team will be in touch to discuss the next steps.Please note that if you meet the eligibility criteria for this study, you will be asked to provide documentation confirming your diagnosis before your participation can be confirmed. This could include a letter from your healthcare professional or relevant medical documentation showing your diagnosis.Any documentation provided will be treated confidentially and handled securely in accordance with applicable data protection requirements.We are committed to protecting the personal data of any respondent that participates in the course of our research and as such we seek consent on a regular basis to both maintain and process your personal data. We will always ask for your consent before collecting any personal data, and it is within your rights to withdraw this consent at any point.By answering the following screening questions, you will provide minimal data pertinent to the study, which will be processed in line with GDPR legislation. Are you happy to continue?
Please provide your contact information to stay in touch during the course of the study.
Where did you hear about this study?